v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Oct. 03, 2025
Sep. 27, 2024
Cash flows from operating activities:    
Net income (loss) $ (663,166) $ (121,615)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 217,366 210,394
Impairment of assets 0 5,555
Impairment of goodwill 548,442 0
Stock-based compensation expense 24,809 21,928
Non-cash interest expense 5,120 3,539
Fair value loss (gain) on contingent acquisition shares 1,787 (19,922)
Loss on currency hedges 0 11,123
Deferred income tax expense (benefit) (565) (29,472)
Loss (gain) on sale of property, plant and equipment 1,129 (2,116)
Changes in operating assets and liabilities:    
Trade receivables, net (17) (29,187)
Inventories, net (33,153) (2,844)
Accounts payable 10,345 (11,503)
Other operating assets and liabilities 16,652 (10,706)
Net cash provided by operating activities 128,749 25,174
Cash flows from investing activities:    
Purchases of property, plant and equipment and intangibles (141,122) (127,522)
Payments for acquisitions, net of cash received, and investments (26,859) (765,422)
Cash received upon settlement of derivatives 1,601  
Cash received upon settlement of derivatives   (4,645)
Net cash used in investing activities (166,380) (897,589)
Cash flows from financing activities:    
Proceeds from borrowings on term credit facility 0 400,000
Repayments of borrowings under term credit facility (15,000) (15,000)
Proceeds from borrowings on revolving credit facilities and other 177,000 940,000
Repayments of borrowings on revolving credit facilities and other (136,862) (447,005)
Payment of debt issuance costs 0 (703)
Payments of tax withholding for stock-based awards (3,504) (4,772)
Proceeds from issuance of common stock, net 1,318 1,555
Deferred consideration payments and other (2,437) (7,174)
Net cash provided by financing activities 20,515 866,901
Effect of foreign exchange rates on Cash and cash equivalents 2,566 480
Decrease in Cash and cash equivalents (14,550) (5,034)
Cash and cash equivalents, beginning of period 48,167 44,832
Cash and cash equivalents, end of period 33,617 39,798
Supplemental disclosures - Non-cash investing activities:    
Fair value of contingently issuable shares in business acquisition $ 0 $ 107,877